Intervention Review

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease

  1. Alessandro Squizzato1,*,
  2. Tymen Keller2,
  3. Erica Romualdi3,
  4. Saskia Middeldorp4

Editorial Group: Cochrane Heart Group

Published Online: 19 JAN 2011

Assessed as up-to-date: 27 FEB 2010

DOI: 10.1002/14651858.CD005158.pub3


How to Cite

Squizzato A, Keller T, Romualdi E, Middeldorp S. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD005158. DOI: 10.1002/14651858.CD005158.pub3.

Author Information

  1. 1

    University of Insubria, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine, Varese, Italy

  2. 2

    Academical Medical Center, Cardiology, Amsterdam, Netherlands

  3. 3

    University of Insubria, Department of Clinical Medicine, Varese, Italy

  4. 4

    Academic Medical Center, Department of Vascular Medicine, Amsterdam, Netherlands

*Alessandro Squizzato, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Medicina 1, viale Borri, 57, Varese, 21100, Italy. alexsquizzo@libero.it. alessandro.squizzato@uninsubria.it.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 19 JAN 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fahad S. Hossain, Rohit Rambani, Helen Ribee, Lutz Koch, Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties, Journal of Orthopaedics and Traumatology, 2013, 14, 3, 171

    CrossRef

  2. 2
    Kathleen Ann McKibbon, Cynthia Lokker, Arun Keepanasseril, Nancy L Wilczynski, R Brian Haynes, Net Improvement of Correct Answers to Therapy Questions After PubMed Searches: Pre/Post Comparison, Journal of Medical Internet Research, 2013, 15, 11, e243

    CrossRef

  3. 3
    Amit P. Amin, Alok Bachuwar, Kimberly J. Reid, Adnan K. Chhatriwalla, Adam C. Salisbury, Robert W. Yeh, Mikhail Kosiborod, Tracy Y. Wang, Karen P. Alexander, Kensey Gosch, David J. Cohen, John A. Spertus, Richard G. Bach, Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status, Journal of the American College of Cardiology, 2013, 61, 21, 2130

    CrossRef

  4. 4
    Huck-Joo Tan, Sanjiv Mahadeva, Jayaram Menon, Wai Kiat Ng, Imran Zainal Abidin, Francis KL Chan, Khean-Lee Goh, Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding, Journal of Digestive Diseases, 2013, 14, 1
  5. 5
    Tae-Hun Kim, Myeong Soo Lee, Kun Hyung Kim, Jung Won Kang, Tae-Young Choi, Edzard Ernst, Acupuncture for angina pectoris, The Cochrane Library,
  6. 6
    Nyoli Valentine, Floris A Van de Laar, Mieke L van Driel, Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus, The Cochrane Library,
  7. 7
    Benilde Cosmi, How does clopidogrel plus aspirin compare with aspirin alone for the primary and secondary prevention of cardiovascular disease?, Cochrane Clinical Answers,
  8. 8
    Ayeesha K Kamal, Shaista A Siddiqi, Imama Naqvi, Maria Khan, Farzin Majeed, Bilal Ahmed, Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack, The Cochrane Library,